Acetazolamide, Nifedipine and Phosphodiesterase Inhibitors: Rationale for Their Utilization as Adjunctive Countermeasures in the Treatment of Coronavirus Disease 2019 (COVID-19)

Curēus (Palo Alto, CA), 2020-03, Vol.12 (3), p.e7343-e7343 [Peer Reviewed Journal]

Copyright © 2020, Solaimanzadeh et al. ;Copyright © 2020, Solaimanzadeh et al. This work is published under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Copyright © 2020, Solaimanzadeh et al. 2020 Solaimanzadeh et al. ;ISSN: 2168-8184 ;EISSN: 2168-8184 ;DOI: 10.7759/cureus.7343 ;PMID: 32226695

Full text available